Your session is about to expire
← Back to Search
Behavioural Intervention
Technology-Based Psychosocial Intervention for HIV (COPPEhR Trial)
N/A
Waitlist Available
Led By Sara Czaja, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
HIV diagnosis for at least 20 years
Age 50+
Must not have
Severe cognitive impairment that limits their ability to use the technology
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-randomization at month 3 and month 6
Summary
This trial aims to develop and test a technology-based program called COPPEhR to help older adults living with HIV who have been diagnosed for over 20 years. The program is designed to enhance social
Who is the study for?
This trial is for older adults with HIV who have been living with the diagnosis for at least 20 years. It aims to help them deal with mental health issues like loneliness and depression by using a technology-based program.
What is being tested?
The study tests a new app called COPPEhR, designed to improve social connections, memory, and resource access. Participants will either use this app on a provided device or just receive the device without the app in a pilot randomized controlled trial.
What are the potential side effects?
Since this intervention involves using an application rather than medication, traditional side effects are not expected. However, participants may experience frustration or stress if they find the technology challenging to use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with HIV for 20 years or more.
Select...
I am 50 years old or older.
Select...
I can use a mouse or keyboard without difficulty.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe difficulty understanding or using technology due to cognitive issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-randomization at month 3 and month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-randomization at month 3 and month 6
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean Difference of Perceived Usefulness and Perceived Ease of Use Questionnaire
Mean Difference of System Evaluation Questionnaire
Secondary study objectives
Change in Loneliness as Measured by UCLA Loneliness Scale
Mean Difference in Score of Quality of Life, assessed using The Quality of Life Questionnaire
Mean Difference in Score of Social Support and Connectivity Assessed using The Social Connectedness Measure
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: COPPEhR InterventionExperimental Treatment1 Intervention
Participants will have access to the COPPEhR system which will provide social support and engagement among older adults diagnosed with HIV.
Group II: Device-only Control ConditionPlacebo Group1 Intervention
Participants will have access to a device only without the COPPEhR system.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,138,841 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,785 Previous Clinical Trials
28,184,706 Total Patients Enrolled
Sara Czaja, PhDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
90 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger